227 related articles for article (PubMed ID: 20018636)
1. Differential association of [11C]PIB and [18F]FDDNP binding with cognitive impairment.
Tolboom N; van der Flier WM; Yaqub M; Koene T; Boellaard R; Windhorst AD; Scheltens P; Lammertsma AA; van Berckel BN
Neurology; 2009 Dec; 73(24):2079-85. PubMed ID: 20018636
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.
Ossenkoppele R; Tolboom N; Foster-Dingley JC; Adriaanse SF; Boellaard R; Yaqub M; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):990-1000. PubMed ID: 22441582
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment no dementia - neuropsychological and neuroimaging characterization of an amnestic subgroup.
Jacova C; Peters KR; Beattie BL; Wong E; Riddehough A; Foti D; Scheltens P; Li DK; Feldman HH
Dement Geriatr Cogn Disord; 2008; 25(3):238-47. PubMed ID: 18264009
[TBL] [Abstract][Full Text] [Related]
4. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
5. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
[TBL] [Abstract][Full Text] [Related]
6. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
[TBL] [Abstract][Full Text] [Related]
7. Detection of Alzheimer pathology in vivo using both 11C-PIB and 18F-FDDNP PET.
Tolboom N; Yaqub M; van der Flier WM; Boellaard R; Luurtsema G; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
J Nucl Med; 2009 Feb; 50(2):191-7. PubMed ID: 19164243
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease.
Anchisi D; Borroni B; Franceschi M; Kerrouche N; Kalbe E; Beuthien-Beumann B; Cappa S; Lenz O; Ludecke S; Marcone A; Mielke R; Ortelli P; Padovani A; Pelati O; Pupi A; Scarpini E; Weisenbach S; Herholz K; Salmon E; Holthoff V; Sorbi S; Fazio F; Perani D
Arch Neurol; 2005 Nov; 62(11):1728-33. PubMed ID: 16286547
[TBL] [Abstract][Full Text] [Related]
9. Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study.
Sarazin M; Berr C; De Rotrou J; Fabrigoule C; Pasquier F; Legrain S; Michel B; Puel M; Volteau M; Touchon J; Verny M; Dubois B
Neurology; 2007 Nov; 69(19):1859-67. PubMed ID: 17984454
[TBL] [Abstract][Full Text] [Related]
10. Relationship of cerebrospinal fluid markers to 11C-PiB and 18F-FDDNP binding.
Tolboom N; van der Flier WM; Yaqub M; Boellaard R; Verwey NA; Blankenstein MA; Windhorst AD; Scheltens P; Lammertsma AA; van Berckel BN
J Nucl Med; 2009 Sep; 50(9):1464-70. PubMed ID: 19690025
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
[TBL] [Abstract][Full Text] [Related]
12. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study.
Edison P; Archer HA; Hinz R; Hammers A; Pavese N; Tai YF; Hotton G; Cutler D; Fox N; Kennedy A; Rossor M; Brooks DJ
Neurology; 2007 Feb; 68(7):501-8. PubMed ID: 17065593
[TBL] [Abstract][Full Text] [Related]
13. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
14. Functional connectivity of the fusiform gyrus during a face-matching task in subjects with mild cognitive impairment.
Bokde AL; Lopez-Bayo P; Meindl T; Pechler S; Born C; Faltraco F; Teipel SJ; Möller HJ; Hampel H
Brain; 2006 May; 129(Pt 5):1113-24. PubMed ID: 16520329
[TBL] [Abstract][Full Text] [Related]
15. Larger temporal volume in elderly with high versus low beta-amyloid deposition.
Chételat G; Villemagne VL; Pike KE; Baron JC; Bourgeat P; Jones G; Faux NG; Ellis KA; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
Brain; 2010 Nov; 133(11):3349-58. PubMed ID: 20739349
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of hippocampal serotonin metabolism in mild cognitive impairment.
Truchot L; Costes SN; Zimmer L; Laurent B; Le Bars D; Thomas-Antérion C; Croisile B; Mercier B; Hermier M; Vighetto A; Krolak-Salmon P
Neurology; 2007 Sep; 69(10):1012-7. PubMed ID: 17785670
[TBL] [Abstract][Full Text] [Related]
18. Molecular imaging in the diagnosis of Alzheimer's disease: visual assessment of [11C]PIB and [18F]FDDNP PET images.
Tolboom N; van der Flier WM; Boverhoff J; Yaqub M; Wattjes MP; Raijmakers PG; Barkhof F; Scheltens P; Herholz K; Lammertsma AA; van Berckel BN
J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):882-4. PubMed ID: 20543188
[TBL] [Abstract][Full Text] [Related]
19. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
20. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]